Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated the press release archive list by adding new entries for **04.20–04.22.2026**, including a **second-quarter 2026 dividend declaration** and **U.S. FDA priority review** related to PADCEV™ + Keytruda®, and an **ASCO 2026 oncology pipeline** update. It also removed earlier items dated **02.06–02.23.2026** from the archive results.
    Difference
    8%
    Check dated 2026-04-24T06:17:17.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A new press release invitation for Pfizer’s April 23, 2026 annual meeting webcast was added to the archive, and an older press release was removed.
    Difference
    2%
    Check dated 2026-04-09T21:35:33.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a dedicated Press Release Archive page and removed the Press Releases and News navigation options, restructuring how press content is accessed.
    Difference
    0.4%
    Check dated 2026-04-02T15:30:31.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Adds four March 2026 press releases to the archive and removes older January–February 2026 entries.
    Difference
    8%
    Check dated 2026-03-26T11:30:44.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added Research and Research and Pipeline categories and included the March 17, 2026 press release Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer. Removed Finance and Financial categories and deleted the February 3 conference call webcast entry from December 2025.
    Difference
    2%
    Check dated 2026-03-19T05:07:34.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Added a March 9, 2026 press release titled Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis under the Research category. Removed the December 17, 2025 press release ‘PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility’ from the archive.
    Difference
    2%
    Check dated 2026-03-11T23:28:03.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.